Tandem Mass Spectrometry Isomer Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for distinguishing dimethylarginine isomers, such as ADMA and SDMA, using mass spectrometry are limited in their ability to accurately differentiate between these isomers due to their similar molecular weights, which hampers diagnostic and therapeutic applications, particularly in identifying vascular disorders like preeclampsia.

Innovation Solution

The method involves ionizing a sample to generate ions, selecting ions within specific mass-to-charge ratios, fragmenting them to produce unique daughter ions, and detecting these ions at distinct m/z signals (46 and 172) to differentiate ADMA and SDMA, with the option to use internal standards containing heavy atoms for quantitation and improved resolution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Difficulty of detecting and measuring

If mass spectrometry is used to detect dimethylarginine isomers, then detection capability is provided, but measurement precision deteriorates due to similar molecular weights

Engineering Contradiction:
Improvedetection capabilityVSAvoidisomer differentiation accuracy
Core Design Contradiction:
Difficulty of detecting and measuringVSMeasurement precision

Solution Approach 1:

The patent segments the detection process into multiple stages: first selecting parent ions based on mass-to-charge ratio, then fragmenting them, and finally detecting specific daughter ions. This segmentation allows differentiation of isomers with similar molecular weights by examining fragmentation patterns rather than relying solely on mass-to-charge ratio.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from detecting only the parent ion mass-to-charge ratio to detecting both parent and daughter ions across multiple mass-to-charge ratios. This dimensional expansion enables isomer differentiation by analyzing the fragmentation spectrum rather than relying on a single mass measurement.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If chromatographic separation is used prior to ionisation, then isomer differentiation is improved, but device complexity and analysis time increase

Engineering Contradiction:
Improveisomer differentiation accuracyVSAvoidchromatographic system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the separation function from the chromatographic system and implements it through mass spectrometry's inherent ability to separate ions based on mass-to-charge ratio and fragmentation patterns. This eliminates the need for complex chromatographic hardware while maintaining isomer differentiation capability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the mechanical chromatographic separation system with a mass spectrometric system that uses electromagnetic fields and fragmentation to achieve separation. This substitution reduces device complexity by eliminating chromatographic columns, mobile phases, and associated instrumentation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If tandem mass spectrometry with fragmentation is used, then isomer differentiation accuracy is improved, but measurement time and energy consumption increase

Engineering Contradiction:
Improveisomer differentiation accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary selection of parent ions based on mass-to-charge ratio before fragmentation. This preliminary action filters out irrelevant ions early in the process, reducing the number of ions that require full fragmentation and analysis, thereby decreasing overall measurement time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies partial fragmentation to achieve sufficient differentiation without complete degradation of all molecular ions. By selecting specific fragmentation patterns that provide adequate isomer distinction without exhaustive breakdown, the method optimizes analysis time while maintaining measurement precision.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables precise detection and measurement of ADMA and SDMA levels in biological samples, facilitating the diagnosis of vascular disorders and monitoring therapeutic responses, thereby improving diagnostic accuracy and treatment efficacy.

Implementation Method 1

ionizing a sample to generate ions

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 2

fragmenting the selected ions to produce daughter ions

Methodology Applied
Scientific EffectFragmentation: Decomposition (biological)

Data Source

PatentEP1996923B1Methods for distinguishing isomers using mass spectrometry
Publication Date: 2012.06.27 REVVITY HEALTH SCIENCES INC
  • EP1996923B1 patent drawingFigure 1
  • EP1996923B1 patent drawingFigure 2A~2B
  • EP1996923B1 patent drawingFigure 3A~3B

AI summary

A method of distinguishing dimethylarginine isomers using tandem mass spectrometry is disclosed. The method includes the steps of ionizing a sample to generate ions; selecting ions having a mass-to-charge ratio (m/z) in an m/z range; fragmenting the selected ions t produce daughter ions; and detecting one or both of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in the sample by detecting one or both of a daughter ion m/z signal at a m/z unique to ADMA and a daughter ion m/z signal at a m/z unique to SDMA.